Cumbo Alexander (CIK 0001685994)

Latest company ownership

Shares held
149,421
Last filed at
Dec 4, 2025
Confidence Score
44.3
2025Q4
Confidence Score History
2023Q4 2025Q4
SRPT - Sarepta Therapeutics, Inc.
Role: EVP, Chief Commercial Officer
Shares held
5,250
Last filed at
Feb 1, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 2, 2025 Dec 4, 2025 Solid Biosciences Inc. CEO Sell 42.5 -10,808 -11.72% ✗ $55.2K
Feb 13, 2025 Feb 18, 2025 Solid Biosciences Inc. CEO Sell 46.3 -11,365 -15.77% ✗ $45K
Dec 2, 2024 Dec 4, 2024 Solid Biosciences Inc. CEO Sell 42.5 -11,114 -22.41% ✗ $62.2K
Dec 2, 2023 Dec 5, 2023 Solid Biosciences Inc. CEO Sell 13.8 -11,757 -40.27% ✓ $32.5K
Dec 13, 2019 Dec 17, 2019 Sarepta Therapeutics, Inc. EVP, Chief Commercial Officer Sell 3.8 -42,000 -88.78% ✓ $5.3M
Mar 28, 2019 Mar 29, 2019 Sarepta Therapeutics, Inc. EVP, Chief Commercial Officer Sell 97.5 +2,711 22.80% ✗ $256.9K
Feb 1, 2019 Feb 1, 2019 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 5.0 -15,000 -49.56% ✓ $2.1M
Aug 8, 2018 Aug 8, 2018 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 40.0 -6,000 -20.86% ✗ $726.1K
Jul 9, 2018 Jul 11, 2018 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 5.0 -33,782 -28.13% ✓ $4.6M
May 22, 2018 May 24, 2018 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 42.5 -1,435 -4.75% ✗ $128K
Mar 15, 2018 Mar 16, 2018 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 32.5 -633 -0.65% ✗ $51.4K
Aug 3, 2017 Aug 7, 2017 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 42.5 -3,169 -11.90% ✗ $120K
Jul 20, 2017 Jul 21, 2017 Sarepta Therapeutics, Inc. SVP, Chief Commercial Officer Sell 10.0 -5,918 -25.96% ✓ $242.6K